BACKGROUND The time course and extent of recovery after revascularization of viable dysfunctional myocardium are variable. Although fibrosis is a major determinant, myocyte structural and molecular remodeling may also play important roles.
(4), regional down-regulation of enzymes involved in oxidative metabolism, and up-regulation of stress proteins that allow the heart to adapt and prevent infarction (5) . In some patients, these adaptations are incomplete, and progressive fibrosis and myocyte loss develops. In others, these adaptations ultimately minimize stress-induced ischemia, which prevents further myocyte death, but at the expense of chronic regional contractile dysfunction.
Although contractile dysfunction in hibernating myocardium can improve after revascularization, complete recovery is infrequent (<25% of patients) (6, 7) , and 1 in 4 dysfunctional segments without fibrosis (determined by magnetic resonance imaging) fail to improve (8) . The time course of functional recovery is also variable. Different studies have demonstrated rapid recovery (9) , recovery within several weeks (10) (11) (12) , and delayed improvement requiring 1 year (13) (14) (15) . This protracted course contrasts with the complete normalization of function within hours or days following acute stunning and short-term hibernation (16) . The roles of myocyte loss (3) and myocardial protein changes (5, 17) in the delayed response to revascularization are unclear.
We performed percutaneous revascularization of swine with chronic hibernating myocardium to determine the initial time course of functional recovery and the cellular mechanisms contributing to persistent dysfunction in the absence of scar. We demonstrated that revascularization of hibernating myocardium stimulated myocyte proliferation (Central Illustration). Nevertheless, functional improvement was delayed and incomplete, with persistent reductions in metabolic and contractile proteins 1 month after revascularization.
METHODS
Experimental procedures and protocols conformed to institutional guidelines for the care and use of animals in research and were approved by the University at Buffalo Institutional Animal Care and Use Committee.
CORONARY ARTERY INSTRUMENTATION.
Juvenile farm-bred pigs (8 to 10 kg) were chronically implanted with a left anterior descending artery (LAD) stenosis to produce hibernating myocardium using a modification of previously published techniques (1) . Fasted pigs pre-medicated with tiletamine 50 mg/ml and zolazepam 50 mg/ml (tiletamine)/ketamine 100 mg/ml (0.037 ml/kg intramuscular [IM]), cefazolin 0.5 g intravenous (IV), and gentamicin 40 mg IV were intubated and anesthetized with isoflurane (1% to 2%).
A thoracotomy was performed in the fourth left intercostal space. The proximal LAD was implanted with a short piece of expandable 1.5-mm internal diameter silicone tubing with a longitudinal slit for vessel insertion (18) . It was secured with circumferential sutures that could be expanded using standard angioplasty balloon inflation pressures. The chest was closed, intercostal nerves were infiltrated with 2% lidocaine, and the pneumothorax was evacuated. Postoperative antibiotics and analgesics (butorphanol 0.025 mg/kg) were administered as needed for pain. were reduced in hibernating myocardium (pre-PCI). Flow reserve normalized 2 h later (post-PCI), but LAD wall thickening remained depressed. Abbreviations as in Figure 1 . PROTEOMIC PROFILING. Samples for proteomics taken from the LAD subendocardium were immediately flash-frozen at À80 C. We used 2-dimensional differential in-gel electrophoresis (2D-DIGE) to assess protein expression, using published techniques (5, 17) , as described in the Online Appendix. Total protein extracted from hibernating swine that were revascularized (n ¼ 12) and nonrevascularized (n ¼ 12)
were compared with a pooled sham control sample (5) . Samples were labeled with CyDye DIGE fluor, run on 2D gels, scanned, and imported into DeCyder [20]). Selected enzyme activities were assayed as described (5) .
MYOCYTE NUCLEAR DENSITY AND MORPHOMETRY.
Myocyte nuclear density was quantified using hematoxylin and eosin-stained sections (3 Table 2 summarizes the effects of revascularization on proteomic adaptations in hibernating myocardium (5, 17, 22) , and proteins correlating with increases in flow and function after revascularization are summarized in the heat map ( Figure 4) . Figure 5 summarizes average changes in selected proteins from each category (proteins italicized in Table 2 ). In general, reductions in the levels of contractile proteins and metabolic enzymes persisted after revascularization. To explain the increased myocyte nuclear density, we evaluated the effects of revascularization on indexes of myocyte proliferation. The levels of Ki-67, a Figure 5 . †p < 0.05 versus sham. ‡p < 0.05 versus hibernating.
Abbreviation as in Table 1 .
marker of cell cycling, and the mitotic marker, phospho-histone-H3 (pHH3), were no different in LAD myocytes from sham and nonrevascularized animals.
In contrast, the levels of Ki-67 increased from 410 AE 82 to 2,109 AE 400 nuclei/10 6 myocyte nuclei after revascularization ( Figure 8A) . Likewise, myocyte pHH3 levels increased from 9 AE 5 to 350 AE 50 nuclei/ 10 6 myocyte nuclei ( Figure 8B) . Resident cardiac stem cells (LAD c-Kit þ /CD45 À cells) ( Figure 8C) were rare in shams (20 AE 11 cells/10 6 myocyte nuclei; n ¼ 6), but the levels tended to be higher in hibernating myocardium (178 AE 59 cells/10 6 myocyte nuclei; n ¼ 7; Following revascularization and the alleviation of ischemia, up-regulated (red) stress and cytoskeletal proteins and glycolytic enzymes generally normalized (yellow).
In contrast, many metabolic and contractile protein levels remained depressed (green) 4 weeks after revascularization. Abbreviation as in Figure 1 . (13, 14) . This is in part due to variable degrees of fibrosis and subendocardial infarction, but even completely viable myocardium exhibits variability. This likely reflects the underlying mechanisms of dysfunction, which arise from reversible ischemia (acute stunning, chronic stunning, and chronic hibernating myocardium) (23) . The spectrum of viable dysfunctional myocardium leads to heterogeneity in the extent of myocyte loss (3, 24) and variability in chronic molecular adaptations induced in response to reversible ischemia (5, 17) . We previously demonstrated that similar degrees of chronic contractile dysfunction from a chronic stenosis result in variable degrees of myocyte loss and proteomic remodeling (17, 24) . These variations are related to physiological stenosis severity, with more profound abnormalities developing in hibernating myocardium where coronary flow reserve becomes critically impaired.
Our results in swine with chronic hibernating myocardium excluded infarction as a covariate and up-regulation of stress and cytoskeletal proteins, as previously described (5, 27) . Other investigators have shown that up-regulated stress and cytoskeletal proteins normalize 1 month after revascularization, accompanied by reductions in the amount of interstitial connective tissue (26, 28) . In contrast, revascularization had only modest effects on metabolic enzyme levels, and reductions in contractile protein levels persisted. We previously demonstrated that regional metabolic protein levels and mitochondrial oxygen consumption progressively decline as stenosis severity increases in viable dysfunctional myocardium (5, 17, 22, 29) . Consonant with our findings, to dobutamine persisted, suggesting that mitochondrial dysfunction continued to limit oxygen consumption during beta-adrenergic stimulation (30, 31) .
This attenuated response could also reflect (19) . Thus, proliferation indexes were 1 to 2 orders of magnitude higher than myocyte apoptosis at this time, resulting in a net increase in myocyte number. These findings suggest that de novo myocyte formation with delayed maturation may contribute to delayed functional recovery. The observation that revascularization stimulates new myocyte formation is also reinforced by recent clinical observations. First, some patients with reversible dyssynergic myocardium have regional wall thinning that reverses after revascularization (34) . (38, 39) . Future studies with a longer follow-up period are necessary to definitively address this question.
Finally, proteomics involves the parallel analysis of multiple proteins on a 2-dimensional gel, which can lead to false discovery of differential protein expression via type I errors (40) . These can be minimized using large samples, as employed in our study, which reduces the impact of biological and experimental variability. Nearly all protein changes in nonrevascularized animals were previously reported in independent experiments using the same experimental approach in this model and in an expanded protein analysis using label-free quantification with LC/MS (22) .
CONCLUSIONS
Our study demonstrated that, even in the absence of infarction, the delayed improvement in LV function after revascularization of hibernating myocardium was associated with an incomplete reversal of the molecular phenotype and the stimulation of new cardiomyocytes originally lost via regional apoptosis from reversible ischemia. Thus, adjunctive treatments, such as intracoronary stem cells (21) and growth factors (19) , may accelerate functional recovery following revascularization of high-risk patients with heart failure, as well as those in whom complete revascularization is not technically feasible. Studies evaluating hybrid strategies to treat viable dysfunctional myocardium will be needed to test these hypotheses. 
